The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for January 2025 (PDF).
This issue advises clinicians to be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor agonists who undergo surgery or procedures with general anaesthesia or deep sedation. Primary care clinicians should advise patients to make surgical teams and anaesthetists aware if they are using these types of medicine.
Lastly, this issue contains a summary of letters to healthcare professionals in December. These generally related to supply issues and recalls but included a defective medication notice for Medikinet® describing and issue affecting the colour appearance of the capsules with no impact on efficacy and notice that Fusidic acid 1% eye drops intended for the Chinese market are being imported and repackaged to ease supply constraints.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.